Evidence map›Paper›PMID 41460853›Full record

ArticlePloS one2025

Intersectional stigma and adherence to antiretroviral (ART) among sexual minority men (SMM) living with HIV in Nigeria: A Qualitative Inquiry.

Adedotun Ogunbajo, Oluwatimilehin Sotubo, Kehinde Okanlawon, Elizabeth Shoyemi, Olakunle Oginni, Kenneth H Mayer

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adedotun OgunbajoRAND Corporation, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0002-3074-6431
Oluwatimilehin SotuboRAND Corporation, Los Angeles, California, United States of America.
Kehinde OkanlawonSocial Inclusion, Justice and Empowerment Initiative, Minna, Nigeria.
Elizabeth ShoyemiCentre For Population Health Initiatives, Lagos, Nigeria.
Olakunle OginniThe Wolfson Centre for Young People's Mental Health, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, United Kingdom.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, Massachusetts, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSexual minority men (SMM) living with HIV in Nigeria experience suboptimal outcomes on the HIV care continuum. Experiences of intersectional stigma has been linked to lower likelihood of engagement in HIV services, but little is known about the effects of intersectional stigma on HIV care outcomes for SMM in Nigeria. The current study explored experiences of intersectional stigma among SMM living with HIV in Lagos, Nigeria and its' impact on engagement in HIV care.

methodsBetween January and February 2022, we conducted semi-structured individual interviews with 30 SMM living with HIV in Lagos, Nigeria and 38 healthcare providers that provide HIV prevention and care services to SMM.

resultsWe found that while participants described experiencing both HIV and sexual minority stigma, they believed sexual minority identity stigma to be more common than HIV-related stigma. Additionally, most participants believed they experience intersectional stigma, especially enacted and anticipated stigma, from their HIV status and sexual minority identity. Respondents utilized various strategies, both negative and positive, to cope with stigma including substance use, identity concealment, social isolation, support systems, and engaging in various hobbies as a form of self-care. Lastly, while most healthcare providers believe that stigma negatively influenced SMM ability to fully engage in HIV care, most SMM believed stigmatization had minimal to no effect on their engagement in HIV care. DISCUSSION: Our findings underscore the importance of developing community (SMM specifically) informed, evidence-based health interventions aimed at reducing the effect of stigma on engagement in HIV care among Nigerian SMM living with HIV, to improve their overall health and quality of life.

Indexed as

Anti-Retroviral AgentsHIV InfectionsMedication AdherenceSexual and Gender MinoritiesSocial StigmaAdultHumansMaleMiddle AgedNigeriaQualitative ResearchYoung AdultAnti-Retroviral Agents

Identifiers

PMID41460853
PMCPMC12747391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.